Fatty acids, platelets and monocytes. Something to do with atherogenesis

Area of Science:

• Immunology
• Biochemistry
• Cardiovascular Science

Background:

• Monocyte activation exhibits significant inter-individual variability.
• Lipopolysaccharides (LPS) are potent activators of monocytes.
• Intracellular signaling pathways underlying monocyte activation are complex.

Purpose of the Study:

• To investigate the intracellular signals involved in monocyte activation.
• To elucidate the role of fatty acids and platelets in lipopolysaccharide-induced monocyte activation.
• To explore potential links between monocyte activation patterns and atherosclerosis susceptibility.

Main Methods:

• Measurement of induced thromboplastin synthesis as a marker of monocyte activation.
• Use of phospholipase A2 and lipoxygenase inhibitors (nordihydroguaiaretic acid) to probe signaling pathways.
• Experimental manipulation of platelet content in blood samples.
• Assessment of the impact of cod liver oil and aspirin on monocyte activation.

Main Results:

• Inhibition of phospholipase A2 blocked LPS-induced thromboplastin synthesis, indicating arachidonic acid release is crucial for monocyte activation.
• Lipoxygenase inhibition showed differential effects based on individual response levels.
• Aspirin intake increased monocyte activation, attributed to platelet effects.
• Platelets significantly enhanced LPS-induced monocyte activation, particularly in high responders.
• Substitution of platelets altered monocyte activation levels, confirming their modulatory role.
• Cod liver oil intake reduced induced thromboplastin synthesis.

Conclusions:

• Fatty acids, particularly arachidonic acid, play a central role in monocyte activation.
• Platelets significantly influence the magnitude of monocyte activation in response to LPS.
• Individuals with high monocyte activation responses may have a greater susceptibility to atherosclerosis.